TrialCancer immunology, immunotherapy : CII2012

DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time.

Lindsey Chudley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.